GT Biopharma, Inc. (GTBP)

0.7177 +0.06 (+8.74%) USD  |  NASDAQ  |  Jan 15, 11:29
More

GT Biopharma Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for GTBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
SELLAS Life Sciences Group, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade